EXANE DERIVATIVES - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$966,000
+13.4%
900.0%0.00%
Q1 2022$852,000
-18.0%
900.0%0.00%
Q4 2021$1,039,000
+21.0%
900.0%0.00%
Q3 2021$859,000
+4.5%
900.0%0.00%
Q2 2021$822,000
-7.5%
900.0%0.00%
Q1 2021$889,000
-57.2%
900.0%0.00%
-100.0%
Q4 2020$2,078,000
+63.5%
900.0%0.00%
Q3 2020$1,271,000
-6.3%
900.0%0.00%
Q2 2020$1,357,000
-91.8%
90
-95.0%
0.00%
-100.0%
Q1 2020$16,548,000
-81.9%
1,791
-79.6%
0.01%
-70.6%
Q4 2019$91,402,000
+29.5%
8,8000.0%0.02%
+30.8%
Q3 2019$70,562,000
-35.7%
8,8000.0%0.01%
-31.6%
Q2 2019$109,782,000
-8.2%
8,8000.0%0.02%
-20.8%
Q1 2019$119,633,000
+42.0%
8,8000.0%0.02%
+60.0%
Q4 2018$84,278,000
-20.8%
8,8000.0%0.02%
-25.0%
Q3 2018$106,352,000
-22.6%
8,8000.0%0.02%
-13.0%
Q2 2018$137,398,0008,8000.02%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders